Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM).

Vincent HarlayRomain AppayCéline BequetGregorio PetrirenaChantal CampelloMaryline BarriéDidier AutranThomas GraillonSébastien BoissonneauHenry DufourDominique Figarella BrangerLaetitia PadovaniAnne BarlierIsabelle NanniEmeline TabouretOlivier Chinot

Published in: Neuro-oncology practice (2023)

BO-GBM constitute a large and heterogeneous population in which one-third of patients is amenable to the standard of care, with survival outcome close to one of the patients who underwent surgery. Reliable criteria are needed to help select patients for adequate treatment while new strategies are warranted for BO-GBM unfit for RT.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
squamous cell carcinoma
wild type
radiation therapy
locally advanced
acute coronary syndrome
patient reported
replacement therapy
surgical site infection